Today: 24 April 2026
Palantir shares jump on fresh $200 target as Thiel sale plan keeps traders edgy
4 March 2026
2 mins read

Palantir shares jump on fresh $200 target as Thiel sale plan keeps traders edgy

NEW YORK, March 4, 2026, 07:57 EST

  • Palantir shares picked up roughly 1.4% in premarket action
  • Rosenblatt upped its price target to $200, previously $150, while sticking with its buy rating
  • U.S. defense AI policy changes are drawing investor attention after fresh restrictions landed on rival technologies.

Shares of Palantir Technologies Inc climbed roughly 1.4% ahead of the open on Wednesday, after Rosenblatt Securities bumped its price target on the data analytics company to $200, up from $150. The firm maintained its buy rating.

The call came while the Pentagon was reassessing its approach to purchasing and deploying commercial AI, following a senior official’s warning that certain contract terms might lock down tools during combat planning. Large language models—AI trained on vast text datasets—can respond to prompts by generating answers and plans.

The vendor roster is under pressure now, too. Defense contractors are moving to drop Anthropic’s Claude, following President Donald Trump’s directive for a government-wide phase-out. The Pentagon has also labeled the company a supply-chain risk. Still, some attorneys argue the wider ban on contractors could face legal hurdles.

Reuters reported Monday that the U.S. State Department, Treasury, and Health and Human Services instructed employees to discontinue using Anthropic’s products, directing them to use alternatives including OpenAI’s ChatGPT and Google’s Gemini instead.

Palantir’s bread and butter has been government and defense contracts for years. Back in July, the U.S. Army announced plans to consolidate a slew of software deals into one enterprise contract with Palantir, potentially valued at $10 billion across a decade. Still, the Army emphasized there are no guaranteed new buys in the agreement.

Insider selling cropped up again this week. According to a Form 144 filing the SEC logged late Monday, STS Holdings II LLC—controlled by Palantir co-founder Peter Thiel—put forward plans to unload as many as 2 million Class A shares, with the total market value pegged at roughly $280 million.

Executives at the company aren’t mincing words. “If you have ever considered returning to Palantir, this is the week to do it,” Ted Mabrey, Palantir’s global head of commercial, wrote in a post, adding a Tolkien reference for alumni: “The Shire is calling.” Business Insider

Guardian Premier Solutions, a defense contractor based in San Antonio, has taken Palantir to Texas state court, accusing the company of fraud and breach of contract over a partnership program that, according to the local report, cost roughly $709,000 and failed to deliver the business referrals it promised. The report also noted that Palantir hadn’t filed a response to the suit.

Traders are eyeing whether Washington’s stricter contract guardrails mean more projects for integrators such as Palantir. Another read: the spending might just favor model providers and cloud players already wired into government channels.

Still, risks stand out. Should the Anthropic ban get rolled back or limited, the procurement shift might lose steam, and Palantir’s lofty valuation doesn’t tolerate much misstep. Defense-focused gainers often see a quick pullback from investors once the story quiets down.

Stock Market Today

  • XPeng Shares Slide Amidst Mixed Financials and Valuation Debate
    April 24, 2026, 4:50 PM EDT. XPeng (NYSE:XPEV) shares have declined over 16% in the past month and 17% over three months, reflecting short-term selling pressure despite a 63.4% total shareholder return over three years. The electric vehicle maker reported annual revenue of CN¥76.7 billion with 15.4% growth but posted a net loss of CN¥1.1 billion, although net income growth improved 45.9%. Analysts remain divided on valuation: the popular model values XPeng shares at $28.16, signaling undervaluation versus the $15.90 closing price, driven by aggressive overseas expansion and improving margins. Yet a discounted cash flow model pegs fair value at $7.69, suggesting shares may be overvalued. Market watchers face a tug-of-war between growth optimism and risks from price competition and capital needs.

Latest article

Meta’s Amazon Chip Deal Shows AI Race Is Moving Beyond Nvidia GPUs

Meta’s Amazon Chip Deal Shows AI Race Is Moving Beyond Nvidia GPUs

24 April 2026
Meta has signed a multiyear deal worth billions to use Amazon Web Services’ Graviton5 chips for AI, deploying tens of millions of cores. Meta plans 2026 capital spending of up to $135 billion and will cut about 8,000 jobs, with layoffs effective May 20. Meta shares rose $16.87 to $676.02 near the U.S. close; Amazon gained $8.87 to $263.95. Meta will report first-quarter results after the market closes April 29.
Liberty Broadband Stock Plunges 26% as Charter Earnings Jolt Merger Bet

Liberty Broadband Stock Plunges 26% as Charter Earnings Jolt Merger Bet

24 April 2026
Liberty Broadband shares dropped about 26% Friday, mirroring a plunge in Charter Communications after Charter reported losing 120,000 internet customers last quarter, more than expected. Liberty holders are set to receive Charter stock under a pending merger, tying Liberty’s value to Charter’s share price. Charter closed down 26% at $179.04. Liberty’s Class A and C shares traded near $41.65 late in the session.
Ouster Stock Jumps as Atlanta Traffic Deal Puts BlueCity Near 2026 World Cup Sites

Ouster Stock Jumps as Atlanta Traffic Deal Puts BlueCity Near 2026 World Cup Sites

24 April 2026
Ouster Inc shares climbed 6.7% to $28.17 Friday after announcing its BlueCity lidar traffic system will be deployed at over 30 Atlanta intersections ahead of the 2026 FIFA World Cup. The expansion, in partnership with Georgia DOT and Southern Lighting & Traffic Systems, builds on earlier installations near Mercedes-Benz Stadium. Ouster will report first-quarter results May 5.
FDA hits Novo Nordisk with another Ozempic ad warning — second strike in weeks
Previous Story

FDA hits Novo Nordisk with another Ozempic ad warning — second strike in weeks

Petrobras won’t rush Brazil fuel price changes after Iran conflict spikes oil, CEO says
Next Story

Petrobras won’t rush Brazil fuel price changes after Iran conflict spikes oil, CEO says

Go toTop